Summary
- Current Price
- As of today, GENB price is $15.42, up +6.64% on
- Current Price All-Time High
- GENB price is currently -0.32% below its historical high of $15.47 set on
- Market Cap
- GENB current market cap is $2B, with unknown 1-year change
- PE Ratio
- GENB PE ratio is unknown
- Revenue
- GENB current annual revenue is $31.89M, up +55.89% year-over-year
- Next Earnings
- The next earnings release for GENB is on
Profile
| Metric | Value |
|---|---|
| Full Name | Generate Biomedicines, Inc. |
| Ticker | NASDAQ: GENB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | generatebiomedicines.com |
| Employees | 312 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $15.42 | |
| Price, 1D Change | +6.64% | |
| $2B | ||
| - | ||
| - | ||
| 1.08 | ||
| $32M | ||
| Revenue, 1Y Change | +55.89% | |
| - | ||
| EPS, 1Y Change | - |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| - | ||
| EPS Estimate | N/A | -$1.89 |
| EPS Est. Change | N/A | - |
| $31.89M | ||
| Revenue Estimate | N/A | $25.37M |
| Revenue Est. Change | N/A | -20.44% |
| Current Price | $15.42 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.89 | N/A | - | |
| -$2.12 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $25.37M | N/A | - | |
| $23.83M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $15.42 | |
| $12.48 | ||
| SMA 200 vs Price | -19.09% | |
| $12.48 | ||
| SMA 50 vs Price | -19.09% | |
| 1.08 | ||
| $0.92 | ||
| 71.35 | ||
| 62.80% | ||
| 84.62% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $31.89M | ||
| - | ||
| - | ||
| - | ||
| -$235.07M | ||
| - | ||
| -$203.15M | ||
| - | ||
| -$208.23M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.11 | ||
| 2.85 | ||
| - | ||
| -195.13 | ||
| N/A | - | |
| -3.20 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$615.97M | ||
| $121.65M | ||
| $330.18M | ||
| $234.37M | ||
| $953.38M | ||
| $82.20M | ||
| $68.53M | ||
| - | ||
| $3.84M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $266.96M | ||
| $266.96M | ||
| - | ||
| $42.26M | ||
| $13.18M | ||
| $1.14M | ||
| $163.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$200.62M | ||
| $116.77M | ||
| $28.06M | ||
| $3.51M | ||
| -$204.13M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | ||
| Piper Sandler | ||
| Morgan Stanley | ||
| Guggenheim | ||
| Goldman Sachs | ||
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
Screeners with GENB
FAQ
What is the ticker symbol for Generate Biomedicines, Inc.?
The ticker symbol for Generate Biomedicines, Inc. is NASDAQ:GENB
Does Generate Biomedicines, Inc. pay dividends?
No, Generate Biomedicines, Inc. does not pay dividends
What sector is Generate Biomedicines, Inc. in?
Generate Biomedicines, Inc. is in the Healthcare sector
What industry is Generate Biomedicines, Inc. in?
Generate Biomedicines, Inc. is in the Biotechnology industry
What country is Generate Biomedicines, Inc. based in?
Generate Biomedicines, Inc. is headquartered in United States
When did Generate Biomedicines, Inc. go public?
Generate Biomedicines, Inc. initial public offering (IPO) was on February 27, 2026
Is Generate Biomedicines, Inc. in the S&P 500?
No, Generate Biomedicines, Inc. is not included in the S&P 500 index
Is Generate Biomedicines, Inc. in the NASDAQ 100?
No, Generate Biomedicines, Inc. is not included in the NASDAQ 100 index
Is Generate Biomedicines, Inc. in the Dow Jones?
No, Generate Biomedicines, Inc. is not included in the Dow Jones index
When does Generate Biomedicines, Inc. report earnings?
The next expected earnings date for Generate Biomedicines, Inc. is May 29, 2026
Data Sources & References
- GENB Official Website generatebiomedicines.com
- GENB Profile on Yahoo Finance finance.yahoo.com/quote/GENB
- GENB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/genb